D-penicillamine-lnduced crescentic glomerulonephritis and antimyeloperoxidase antibodies in a patient with scleroderma

American Journal of Nephrology

Volumn 17, Issue 6, 1997, Pages 528-532

  Karpinski, Jolanta ^a   Jothy, Serge ^a   Radoux, Victor ^b   Levy, Mortimer ^a   Baran, Dana ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Anti myeloperoxidase antibodies; D Penicillamine; Drug side effects; Glomerulonephritis; Prognosis; Scleroderma; Treatment

Indexed keywords

ANTIRHEUMATIC AGENT; CYCLOPHOSPHAMIDE; HISTONE ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; PENICILLAMINE; PREDNISONE;

AGED; ARTICLE; CASE REPORT; FEMALE; HEMODIALYSIS; HUMAN; HUMAN TISSUE; IMMUNE COMPLEX DEPOSITION; KIDNEY BIOPSY; KIDNEY FAILURE; PRIORITY JOURNAL; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; SCLERODERMA;

AGED; AUTOANTIBODIES; BIOPSY; FEMALE; GLOMERULONEPHRITIS; HUMANS; KIDNEY GLOMERULUS; MICROSCOPY, ELECTRON; PENICILLAMINE; PEROXIDASE; SCLERODERMA, SYSTEMIC;

EID: 0030666491     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000169183     Document Type: Article

References (24)

1. Jaffel A: Induction of autoimmune syndromes by penicillamine therapy in rheumatoid arthritis and other diseases. Springer Semin Immunopathol 1981;4:193-207.
2. Dawkins RL, Zilko PJ, Carrano J, Garlepp MJ, McDonald BL: Immunobiology of D-penicillamine. J Rheumatol 1981:8(suppl 7):56-61.
3. Hall CL, Jawad S, Harrison PR, MacKenzie JC, Bacon PA, Klouda PT, Maclver AG: Natural course of penicillamine nephropathy: A long-term study of 33 patients. Br Med J 1988; 296:1083-1086.
4. Gibson T, Burry HC, Ogg C: Goodpasture’s syndrome and D-penicillamine. Ann Intern Med 1976:84:100.
5. Gavaghan TE, McNaught PJ, Ralston M, Hayes JM: Penicillamine-induced Goodpasture’s syndrome: Successful treatment of a fulminant case. Aust N Z J Med 1981:11:261-265.
6. Swainson CP, Thomson D, Short AIK, Winncy RJ: Plasma exchange in the successful treatment of drug-induced renal disease. Nephron 1982;30:244-249.
7. Banfi G, Imbasciati E, Guerra L, Mihatsch MJ, Ponticelli C: Extracapillary glomerulonephritis with necrotizing vasculitis in 7J-penicillamine-treated rheumatoid arthritis. Nephron 1983: 33:56-60.
8. Sadjadi SA, Seelig MS, Berger AR, Milstoc M: Rapidly progressive glomerulonephritis in a patient with rheumatoid arthritis during treatment with high-dosage D-penicillamine. Am J Nephrol 1985:5:212-216.
9. Williams AJ, Fordham JN, Barnes CG, Goodwin FJ: Progressive proliferative glomerulonephritis in a patient with rheumatoid arthritis treated with D-penicillamine. Ann Rheum Dis 1986:45:82-84.
10. Peces R, Riera JR, Arboleya LR, Lopez-Larrca C, Alvarez J: Goodpasture’s syndrome in a patient receiving penicillamine and Carbimazole. Nephron 1987;45:316-320.
11. Macarron P, Garcia Diaz JE, Azofra JA, Martin de Francisco J, Gonzalez E, Fernandez G, Sampcdro J: D-Penicillamine therapy associated with rapidly progressive glomerulonephritis. Nephrol Dial Transplant 1992:7:161-164.
12. Jones BF, Major GAC: Crescentic glomerulonephritis in a patient taking penicillamine associated with antineutrophil cytoplasmic antibody. Clin Nephrol 1992:38:293.
13. Almirall J, Alcorta I, Botev A, Revert L: Penicillamine-induced rapidly progressive glomerulonephritis in a patient with rheumatoid arthritis. Am J Nephrol 1993;13:286-288.
14. Donnely S, Levison DA, Doyle DV: Systemic lupus erythematosus-like syndrome with focal proliferative glomerulonephritis during D-penicillamine therapy. BrJ Rheumatol 1993:32: 251-253.
15. Gaskin G, Thompson EM, Pusev CD: Goodpasture-like syndrome associated with anti-myeloperoxidase antibodies following penicillamine treatment. Nephrol Dial Transplant 1995;10:1925-1928.
16. Sternlieb I, Bennett B, Scheinberg IH: D-Peni-cillaminc-induccd Goodpasture’s syndrome in Wilson’s disease. Ann Intern Med 1975:82: 673-676.
17. Ntoso KA, Tomaszewski JE, Jimenez SA, Neilson EG: Penicillamine-induced rapidly progressive glomerulonephritis in patients with progressive systemic sclerosis: Successful treatment of two patients and a review of the literature. Am J Kidney Dis 1986;8:159-163.
18. Devogelaer JP, Pirson Y, Vandcnbrouckc JM, Cosyns JP, Brichard S, Nagant de Deux-chaisnes C: D-Penicillaminc-induced crescentic glomerulonephritis: Report and review of the literature. J Rheumatol 1987; 14:1036-1041.
19. Endo H, Hosono T, Kondo H: Antineutrophil cytoplasmic antibodies in 6 patients with renal failure and systemic sclerosis. J Rheumatol 1994:21:864-870.
20. Mattoff DS, Kaplan MM: D-Penicillamine-induccd Goodpasture’s-like syndrome in primary biliary' cirrhosis - Successful treatment with plasmapheresis and immunosuppression. Gastroenterology 1980:78:1046-1049.
21. Abreo K, Abreo F, Mitchell B, Schloemer G: Idiopathic crescentic membranous glomerulonephritis. Am J Kidney Dis 1986;8:257-261.
22. Yung RL, Richardson BC: Drug-induced lupus. Rheum Dis Clin North Am 1994:20:62-86.
23. Enzenauer RJ, West SG, Rubin RL: D-Penicil-lamine-induced lupus erythematosus. Arthritis Rheum 1990;33:1582-1585.
24. Malhieson PW, Thiru S, Oliviera DBG: Mercuric chloride-treated Brown Norway rats develop w idespread tissue injury including necrotizing vasculitis. Lab Invest 1992;67:121-129.